Our comparison of two DCIS regions in Sample #1 reveals reduced myoepithelial markers KRT15, KRT23, and ALDH1A3 and increased invasive markers in DCIS #2 (Fig. 4) which could indicate a higher grade tumor. The gene discussed is KRT23; the disease is ductal breast carcinoma in situ.